Liquid Biopsy in Cancer
NSW Cancer Research Education - Statewide Seminar Series 2024
12:30 - 1:30pm
Liquid biopsies of blood, urine, or other body fluid such as ascites are gaining interest in cancer diagnostics and treatment. Liquid biopsies are used to identify presence of cancer cells or small fragmented pieces of DNA, RNA, or other molecules released by cancer cells
into body fluids. Liquid biopsies may be used to detect cancer at an early stage and hold great promise for population screening for early cancer detection.
Liquid biopsy allows multiple samples to be taken over time, which may help to understand genetic or molecular changes as they are taking place to improve treatment approaches and outcomes for patients. It may also be used to determine how well treatment is working and to detect recurrence earlier.
In this session Professor Helen Rizos will discuss liquid biopsies in melanoma – how they can monitor response, predict patient outcomes and current limitations in the application of liquid biopsies and Dr Kristina Warton will present on using liquid biopsies for early detection
of gynaecological cancers.